article thumbnail

Moderna cuts sales forecasts for its COVID-19 vaccine

Bio Pharma Dive

The biotech dialed back its financial projections after reporting lower-than-expected sales for the shot, which currently remains the company’s only marketed product

Sales 290
article thumbnail

Pfizer’s Covid-19 vaccine sales forecasts upgraded with sales of $37bn in 2022

Pharmaceutical Technology

Pfizer and BioNTech’s Covid-19 vaccine, Comirnaty, had a phenomenal year with forecast sales of $37bn in 2022. Comirnaty is the leading prophylactic vaccine for Covid-19 and is expected to generate an additional $2.8bn in sales in 2022 compared to GlobalData’s H1 2022 forecast.

Sales 246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

J&J puts focus on cancer drugs in push to reach 2025 sales target

Bio Pharma Dive

The drugmaker reported fourth quarter revenue that fell short of forecasts, but reiterated confidence in reaching a $60 billion pharmaceutical sales goal

Sales 297
article thumbnail

Bluebird bolsters balance sheet with sale of second regulatory fast pass

Bio Pharma Dive

The gene therapy developer will receive $95 million from Bristol Myers Squibb, slightly less than it got in the recent sale of another priority review voucher

Sales 301
article thumbnail

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

article thumbnail

Sales manager

Pharma Phorum

Create and disseminate sales support materials. Manage and develop sales team (sales manager role only). Proven experience of working as part of a sales team. Proven work experience working in a sales-based role. The post Sales manager appeared first on.

Sales 98
article thumbnail

Bristol Myers CAR-T sales rise, despite production problems

Bio Pharma Dive

A manufacturing issue for Breyanzi, meanwhile, impacted sales Demand has increased faster than Bristol Myers can make Abecma, although the company said supply is improving.

Sales 283
article thumbnail

Magenta to explore sale, merger after study setback

Bio Pharma Dive

The biotech recently stopped a trial of its experimental conditioning regimen over safety concerns. Now it’s halting further development work as it undertakes a strategic review

Sales 314
article thumbnail

Seagen reportedly in sales talks again, this time with Pfizer

Bio Pharma Dive

Citing people familiar with the talks, The Wall Street Journal reported over the weekend that Pfizer is trying to acquire Seagen and its suite of cancer therapies in a deal that could be worth more than $30 billion

Sales 275
article thumbnail

Amylyx’s ALS drug sales impress Wall Street

Bio Pharma Dive

In its first full quarter on the market, Amylyx’s Relyvrio generated revenue just shy of $22 million, or roughly five times what some analysts were forecasting a month ago

Sales 238
article thumbnail

Pharma earnings outline drug law’s looming impact on sales, development

Bio Pharma Dive

While many companies are still unsure of the Inflation Reduction Act's effects, some have begun to warn investors about the likelihood of lower sales and reduced profitability

Sales 314
article thumbnail

Lilly reports fast sales for new diabetes drug

Bio Pharma Dive

Still, fourth quarter sales for Mounjaro were slightly below high Wall Street forecasts and didn’t offset falling revenue from Lilly’s COVID-19 antibodies

Sales 158
article thumbnail

Pfizer forecasts steep decline in COVID vaccine, drug sales

Bio Pharma Dive

The company expects yearly revenue from Comirnaty and Paxlovid to fall by nearly two thirds in 2023 amid lower vaccination rates and a shift to private market sales

Sales 158
article thumbnail

Merck reports 2% increase in worldwide sales in Q4 2022

Pharmaceutical Technology

Merck (MSD outside North America) has reported a 2% increase in worldwide sales to $13.83bn in the fourth quarter (Q4) of 2022 from $13.52bn in the previous year’s quarter. The company’s pharmaceutical sales recorded a 1% rise to $12.18bn compared to $12.03bn in the prior-year quarter.

Sales 246
article thumbnail

Aerie’s glaucoma drug journey ends in $770M sale to Alcon

Bio Pharma Dive

The biotech successfully brought two medicines to market, but shares have lost most of their value amid sluggish sales

Sales 275
article thumbnail

J&J predicts faster coronavirus vaccine sales amid debate over boosters

Bio Pharma Dive

billion in sales from its shot this year, despite concerns over protection against variants and significant manufacturing setbacks The pharmaceutical company expects $2.5

Sales 291
article thumbnail

Sales of J&J, Legend cell therapy plateau amid production challenges

Bio Pharma Dive

Carvykti, which was approved a year ago for hard-to-treat multiple myeloma, generated $55 million in fourth quarter sales, the same as it earned between July and September

Sales 158
article thumbnail

Novo obesity drug sales lag as manufacturing problems persist

Bio Pharma Dive

Manufacturing problems continue to weigh on Novo’s Wegovy launch as competition looms from Eli Lilly’s fast-selling diabetes medicine Mounjaro

Sales 291
article thumbnail

US plans shift to private market sales of COVID-19 vaccines, drugs

Bio Pharma Dive

The federal government will begin the transition as early as this fall, clearing the way for drugmakers to control sales and distribution of their shots and therapeutics

Sales 267
article thumbnail

Artificial Intelligence (AI) in Pharma Sales and Marketing

Pharma Mirror

The post Artificial Intelligence (AI) in Pharma Sales and Marketing appeared first on Pharma Mirror Magazine. Pharmaceutical Articles artificial intelligence Pharma Sales and MarketingWhat is AI?

Sales 130
article thumbnail

Gilead sales propped up by COVID-19 drug Veklury

Bio Pharma Dive

Sales of the antiviral drug accounted for a quarter of the biotech's product revenue in the fourth quarter, disguising hits to its business elsewhere

Sales 291
article thumbnail

Novartis sales of Zolgensma gene therapy slow as market shifts

Bio Pharma Dive

Treatment is now mostly of infants newly diagnosed with spinal muscular atrophy, as many of those previously eligible either already received Zolgensma or other drugs from Biogen and Roche

article thumbnail

Sandoz, betting on biosimilar sales, to build new production plant

Bio Pharma Dive

The Novartis division will invest at least $400 million in a new manufacturing facility in Slovenia amid expectations that demand for copycat biologics will surge in the coming years

Sales 180
article thumbnail

Novartis said to be eyeing sale of ophthalmology, respiratory units

Pharma Phorum

Novartis has already spun out its eyecare business Alcon, and is now considering the sale of its ophthalmology and respiratory medicines businesses as it continues a narrowing of its focus, according to media reports.

Sales 124
article thumbnail

Novartis wins FDA approval for new heart drug, but faces uphill sales battle

Bio Pharma Dive

Leqvio, which Novartis acquired for nearly $10 billion two years ago, arrives with high sales expectations. But uptake could be slow as insurers and doctors weigh the drug's safety and cost-effectiveness

article thumbnail

Novartis Explores Sale of Certain Ophthalmology Assets

BioSpace

Novartis Explores Sale of Certain Ophthalmology Assets 3/14/2023

Sales 79
article thumbnail

Eversana aims athletes’ mental coaching at pharma sales reps

Pharma Phorum

Eversana’s suite of commercialisation tools for pharma companies will soon have a new component – cognitive behavioural training tools designed to improve the performance of sales representatives. Digital News Sales and Marketing digital Sales reps Training

Sales 118
article thumbnail

How medical device sales teams can embrace digital transformation

Pharma Phorum

Selling amid a global pandemic has changed the face of sales forever. This is nowhere more pronounced than for medical device sales teams, who typically schedule regular visits to hospitals and doctors’ offices to create a personal, ongoing connection that drives forward the sales process.

Sales 98
article thumbnail

AbbVie cancer drug sales fall as AstraZeneca competitor gains ground

Bio Pharma Dive

Imbruvica, long one of AbbVie’s top-selling medicines, has ceded market share in treating chronic lymphocytic leukemia to AstraZeneca’s Calquence

Sales 275
article thumbnail

Yumanity cutting 60% of employees as it mulls possible sale

Bio Pharma Dive

The layoffs — which, according to Yumanity, should be completed by April — are part of a larger restructuring effort meant to reduce costs after a recent setback to the company's most advanced drug program

Sales 322
article thumbnail

Merck, GSK vaccine sales hit by pandemic as competitors' business booms

Bio Pharma Dive

Both companies blamed the impact of COVID-19 on sharp declines in sales of their shingles, pneumonia and HPV shots

Sales 297
article thumbnail

Sales coaching: preparing for the new reality in pharma

Pharma Phorum

COVID-19 has been a catalyst for a huge amount of change across the pharmaceutical industry, acting as an accelerant for progress in its use of digital technology and prompting a reassessment of how the sales function should work. The industry faces the dawn of a new age in sales coaching.

Sales 97
article thumbnail

Moderna vaccine sales surpass expectations as company looks to fall boosters

Bio Pharma Dive

The trajectory of COVID-19 vaccine sales is now harder to predict amid questions about the rollout of additional doses and whether purchasing in the U.S.

Sales 267
article thumbnail

Merck sees up to $7B in coming sales of coronavirus pill

Bio Pharma Dive

But sales could climb even higher if it works as a preventive treatment too Executives based their projections on contracts already in place for the drug, known as molnupiravir.

Sales 303
article thumbnail

7 commercial, sales, and marketing predictions for 2023

Pharma Phorum

Rarely are organisations able to view HCP relationships holistically – across clinical, medical, and sales – or reap the benefits of creating a unified understanding of the customer. The post 7 commercial, sales, and marketing predictions for 2023 appeared first on.

Sales 105
article thumbnail

Esperion lays off nearly half its workforce as heart drug sales disappoint

Bio Pharma Dive

The company hopes a "streamlined" sales force can turn around a drug launch that's failed to meet expectations amid tough competition from rival medicines

Sales 275
article thumbnail

Pfizer forecasts $100B in sales, fueled by COVID-19 vaccine, pill

Bio Pharma Dive

The company estimated revenue from its COVID-19 vaccine and antiviral pill Paxlovid will total $54 billion this year. Curiously, its stock fell by more than 5

Sales 303
article thumbnail

Pfizer forecasts $15B sales boost from coronavirus vaccine orders

Bio Pharma Dive

The estimate for 2021 sales, which Pfizer splits with partner BioNTech, would make the vaccine one of the highest-selling medicines in the industry

Sales 228
article thumbnail

Gilead, fueled by latest approval, sees CAR-T sales take off

Bio Pharma Dive

After a slow start, Gilead’s CAR-T business is growing fast, enabling it to pull ahead of rival cell therapy developers like Bristol Myers Squibb and Johnson & Johnson

Sales 340
article thumbnail

Biogen's Alzheimer's drug sales remain slow as company warns of further cost cuts

Bio Pharma Dive

Aduhelm sales totaled just $1 million in the fourth quarter as Biogen struggles to win over doctors and insurers. The company said it would reduce expenses by more than currently planned if Medicare limits coverage

Sales 267
article thumbnail

How COVID-19 has changed the role of pharma sales reps

Pharma Phorum

The demise of the pharmaceutical sales representative has been greatly exaggerated over the years. The current restrictions on face-to-face meetings have exacerbated the trend of sales reps’ reduced access to healthcare customers.

Sales 115
article thumbnail

After setbacks, a gene therapy company mulls a sale

Bio Pharma Dive

Sio Gene Therapies, formerly known as Axovant, said it's focused on conserving cash, and has decided to significantly reduce its workforce and terminate licensing agreements on its last two pipeline programs

article thumbnail

Vaccine sales driven down by pandemic's effects on doctor visits

Bio Pharma Dive

Pfizer, Sanofi, GSK and Merck each reported lower vaccine sales as stay-at-home orders kept people from their regular vaccinations

Doctors 237